Skip to main content
Caplight Logo









Anagram

Anagram

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://www.goanagram.com/

Last Round

Series A

Mar 4, 2020

Total Funding Raised

$21.18M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Anagram is a financial software company that provides a unified revenue cycle management SaaS platform that automates vision insurance billing and claims management for eye care providers.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Vertical SaaS, InsurTech

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

revenue cycle managementRCMinsurance billing softwaremedical billingoptometry softwareeligibility verificationclaim processingvertical SaaSpractice managementInsurTechclaim scrubbingvision insurancemedical billing servicebilling automationdenial management

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Anagram Comparables

Compare Anagram with similar companies based on industry and business-model similarity.

Anagram comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
RevCycle Partners
86%
VSP Vision
76%
Crystal Practice Management
76%

Anagram Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 4, 2020
SeedAug 15, 2019
SeedSep 1, 2018

Key People

Founding team and executive leadership

Jeremy Bluvol

CEO

Executive Team

Anagram Investors

Notable investors and investment history

Anagram investors
InvestorRounds
Launchpad Digital HealthSeed, Series A
ManchesterStory GroupSeries A
Rogue Venture PartnersSeed, Series A
FundersClubSeed
Waterline VenturesSeries A
Healthy VenturesSeed, Series A
KEC VenturesSeed, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    Processes hundreds of millions of dollars in eye care billing annually.

  • Mar 13, 2026

    Over 2,000 eye care professionals now use the platform.

Anagram Filings

Explore SEC and related filing metadata, where available.

Anagram filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Anagram's valuation, stock price, and market status.

Is Anagram a public or private company?

Anagram is a private company.

What is the current stock price of Anagram?

Anagram is a private company with no public stock price. No recent secondary market data is available.

How much is Anagram worth (valuation)?

Valuation information for Anagram is not publicly available.

Can I buy Anagram stock?

Anagram shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Anagram's last funding round?

Anagram's most recent funding round was Series A on February 26, 2025.

Who are the main investors in Anagram?

Key investors in Anagram include Madrona Venture Group, ManchesterStory Group.

Will Anagram IPO soon?

No public IPO plans have been announced for Anagram.

How can I track Anagram secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Anagram's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range101
Year Founded2014
Last FundingMar 4, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?